Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- ChecktodayChange DetectedRevision: v3.6.5 now appears on the page, replacing v3.6.4 and signaling an updated site build for the Record History view.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision label on the study record history was updated from v3.6.3 to v3.6.4 to reflect a new site release.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe record history now shows a new revision tag v3.6.3, replacing the previous v3.6.2 in the current view. This indicates a minor metadata update to the page rather than changes to the trial data.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history now reflects a newer revision tag (v3.6.2) replacing the older v3.6.0, signaling a minor backend update to the page rather than a change to trial data. No substantive trial information is modified.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history adds a note that the study is no longer recruiting participants and updates the record revision to v3.6.0, replacing the prior v3.5.5 label.SummaryDifference0.2%

- Check65 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, indicating an update to the page metadata. This reflects an administrative update to the record rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.